Selective antitumor activity of roscovitine in head and neck cancer
Radiation and chemotherapy that are commonly used to treat human cancers damage cellular DNA. DNA damage appears to be more toxic to cancer cells than normal cells, most likely due to deregulated checkpoint activation and/or deficiency in DNA repair pathways that are characteristics of many tumors....
Main Authors: | Gary, Cyril, Hajek, Michael, Biktasova, Asel, Bellinger, Gary, Yarbrough, Wendell G., Issaeva, Natalia |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122414/ |
Similar Items
-
Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
by: Cui, Chunying, et al.
Published: (2013) -
National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database
by: Schwam, Zachary G., et al.
Published: (2015) -
Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer
by: Roh, Jong-Lyel, et al.
Published: (2014) -
Correction: Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
by: Zhang, Zili, et al.
Published: (2013) -
Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
by: Zhang, Zili, et al.
Published: (2013)